Landthaler M - Search Results

1

Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.

Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK. Mühlbauer M, et al. Among authors: landthaler m. Clin Cancer Res. 1999 May;5(5):1099-105. Clin Cancer Res. 1999. PMID: 10353744

2

[MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].

Bosserhoff AK, Golob M, Buettner R, Landthaler M, Hein R. Bosserhoff AK, et al. Among authors: landthaler m. Hautarzt. 1998 Oct;49(10):762-9. doi: 10.1007/s001050050822. Hautarzt. 1998. PMID: 9857251 Review. German.

3

Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas.

Kroiss MM, Bosserhoff AK, Vogt T, Buettner R, Bogenrieder T, Landthaler M, Stolz W. Kroiss MM, et al. Among authors: landthaler m. Melanoma Res. 1998 Dec;8(6):504-9. doi: 10.1097/00008390-199812000-00005. Melanoma Res. 1998. PMID: 9918412

4

Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.

Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M, Stolz W. Glaessl A, et al. Among authors: landthaler m. Arch Dermatol Res. 1999 Feb-Mar;291(2-3):81-7. doi: 10.1007/s004030050387. Arch Dermatol Res. 1999. PMID: 10195394

5

In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.

Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R. Bosserhoff AK, et al. Among authors: landthaler m. J Pathol. 1999 Mar;187(4):446-54. doi: 10.1002/(SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y. J Pathol. 1999. PMID: 10398105

6

Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma.

Bosserhoff AK, Dreau D, Hein R, Landthaler M, Holder WD, Buettner R. Bosserhoff AK, et al. Among authors: landthaler m. Recent Results Cancer Res. 2001;158:158-68. doi: 10.1007/978-3-642-59537-0_16. Recent Results Cancer Res. 2001. PMID: 11092043

7

Association of early malignant melanoma with nevocytic nevi.

Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O. Stolz W, et al. Among authors: landthaler m. Cancer. 1989 Feb 1;63(3):550-5. doi: 10.1002/1097-0142(19890201)63:3<550::aid-cncr2820630325>3.0.co;2-a. Cancer. 1989. PMID: 2643457 Review.

8

Phototherapy-induced elevation of serum level of melanoma inhibitory activity.

Datz E, Zeman F, Koller M, Szeimies RM, Berneburg M, Landthaler M, Bosserhoff AK, Karrer S. Datz E, et al. Among authors: landthaler m. Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):255-260. doi: 10.1111/phpp.12461. Epub 2019 Mar 25. Photodermatol Photoimmunol Photomed. 2019. PMID: 30815924 Clinical Trial.

9

[Classification, diagnosis and differential diagnosis of malignant melanoma].

Stolz W, Landthaler M. Stolz W, et al. Among authors: landthaler m. Chirurg. 1994 Mar;65(3):145-52. Chirurg. 1994. PMID: 8194399 Review. German.

10

p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin.

Vogt T, Zipperer KH, Vogt A, Hölzel D, Landthaler M, Stolz W. Vogt T, et al. Among authors: landthaler m. Histopathology. 1997 Jan;30(1):57-63. doi: 10.1046/j.1365-2559.1996.d01-558.x. Histopathology. 1997. PMID: 9023558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters